Old Drugs, New Bugs
In the short period of human history that antibiotics have been available, humanity faces problems with ever increasing antimicrobial resistance. This has resulted in clinicians having to turn back to using older agents, such as colistin and fosfomycin, which were largely superseded by safer, and often broader spectrum drugs. In addition newer antibiotics (such as ceftazidime/avibactam, ceftobiprole, ceftaroline, tedizolid, plazomycin) have been developed in response to this clinical need. This talk will review the current state of antimicrobial resistance and strategies to deal with this problem.